Dr. Amy Kruse is the GP & CIO of Satori Neuro, a VC fund at Satori Capital.  Her focus is mental health, neurotechnology, and human flourishing.  Previously, Amy was a GP at Prime Movers Lab and led investments in human augmentation. Amy has 20+ years of neuroscience experience spanning an array of positions. She is formerly the CSO at Optios an applied neuroscience company. Amy was also the VP and CTO at Cubic Global Defense overseeing innovation and the R&D portfolio across the entire defense enterprise. Early in her career, she served as a government civilian program manager at DARPA where she created and oversaw the Agency’s first performance-oriented neuroscience programs, with a combined budget of over $300M. She earned a BS in Cell Biology and a PhD in Neuroscience from UIUC.